# Fulcrum Therapeutics, Inc.: Form 8-K, filed Nov 7, 2023

- Company: [Fulcrum Therapeutics, Inc.](/companies/fulc.md) (CIK 1680581)
- Form: 8-K
- Filed: 2023-11-07
- Accepted by EDGAR: Nov 7, 2023, 07:02 ET
- Period: 2023-11-07
- Accession: 0000950170-23-059753
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1680581/000095017023059753/fulc-20231107.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1680581/000095017023059753/

## Items reported

- Item 2.02: Results of operations
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1680581/000095017023059753/fulc-20231107.htm

Filed Nov 7, 2023.
Source: SEC EDGAR, the filing index for accession 0000950170-23-059753. Last ingested by Listed: Oct 27, 2026, 16:11 ET. No prices; not investment advice.